4-OH-E1 : 2-OH-E1 is a ratio that compares how much estrone (E1) your body routes down the 4-hydroxylation pathway (to 4-hydroxyestrone) versus the 2-hydroxylation pathway (to 2-hydroxyestrone). It’s a distribution metric, not a raw estrogen level. On this urine panel, values are typically normalized to creatinine so hydration has less effect.
Why it matters
Both 4-OH-E1 and 2-OH-E1 are catechol estrogens made by Phase I enzymes. The 2-OH route generally produces less estrogenic metabolites, while the 4-OH route forms reactive catechols that your body normally neutralizes via COMT-mediated methylation into methoxy estrogens. The ratio helps show your routing preference between these two pathways. It does not diagnose disease or predict cancer risk by itself; it’s one piece of your estrogen-metabolism picture and should be interpreted with 4-methoxy/2-methoxy partners, overall estrogen output, cycle timing, symptoms, and clinical history.
How to interpret (use your lab’s reference range)
-
Lower ratio (relatively more 2-OH than 4-OH): Often a comfortable pattern when 2-methoxy levels indicate good methylation. Still interpret with total estrogen production and symptoms.
-
Balanced ratio: Suggests a typical split between the 4-OH and 2-OH routes. Confirm that methoxy metabolites are adequate (showing COMT is working) and review the rest of the panel (4-OH %, 2-OH %, 16-OH %, total estrogen output).
-
Elevated ratio (relatively more 4-OH versus 2-OH): Indicates a shift toward 4-hydroxylation. On its own this does not equal high risk, but it’s a cue to check 4-methoxy-E1, 2-methoxy-E1, overall methylation support, oxidative stress, and modifiable factors (see below).
What can influence this ratio
-
Diet & lifestyle: Lower intake of cruciferous vegetables, high alcohol use, tobacco smoke, and habitual intake of charred foods can shift Phase I patterns; inadequate fiber, poor sleep, and high stress may impair downstream clearance.
-
Methylation capacity (COMT) & Phase II pathways: Adequate folate, B12, B6, magnesium, choline/betaine, phytonutrient diversity, and hydration support conversion to methoxy estrogens and excretion.
-
Medications/supplements: Enzyme inducers/inhibitors (some anticonvulsants, PPIs, botanicals like St. John’s wort) and hormonal contraception/HRT change metabolism.
-
Cycle timing & collection: Aim for consistent timing (many labs prefer early follicular) and first-morning urine; creatinine correction helps but extreme dilution/concentration can still nudge near-cutoff results.
What to do next (actionable plan)
-
Confirm properly if results are unexpected: repeat with first-morning urine, consistent cycle timing, and limited alcohol for 24–48 hours before the test.
-
Review partners: Look at 4-OH %, 2-OH %, 16-OH %, and especially 4-methoxy-E1 and 2-methoxy-E1 to ensure catechols are being methylated.
-
Food-first balance: Emphasize cruciferous vegetables (broccoli, kale, cabbage), broad plant diversity, and 25–35 g/day fiber; maintain hydration; prioritize sleep and stress management.
-
Consider clinician-guided supplements only if indicated: Compounds like I3C/DIM can alter Phase I routing, and methylation nutrients may support Phase II—but these should be personalized and re-tested, not self-prescribed.
-
Medication & exposure review: Discuss drugs/botanicals that affect liver enzymes; minimize smoking and excessive alcohol.
Key takeaways
-
The 4-OH-E1 : 2-OH-E1 ratio shows routing between two estrogen pathways; it isn’t a diagnosis or risk score.
-
Elevated ratios signal a relative shift toward 4-hydroxylation and call for a check of methoxy partners and modifiable factors.
-
Aim for balanced pathways and healthy downstream methylation, guided by your clinician and your symptoms.
4-OH-E1:2-OH-E1 (Pre-menopausal)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.